Overview Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and women in the United States. In 2009, an estimated 106,100 new cases of colon cancer and 40,870 new cases of rectal cancer will occur in the United States, and 49,920 people will die of colon and rectal cancers. Patients with lo-calized colon cancer have a 90% 5-year survival rate. CRC mortality can be reduced through early diagnosis and cancer prevention with polypectomy. Therefore, the goal of CRC screening is to detect cancer at an early, curable stage and to detect and remove clinically significant adenomas. Screening tests that can detect both early cancer and adenomatous polyps are encouraged, although the panel recognizes that patient preference and resource accessibility play a large role in test selection. Curent technology falls into 2 broad categories: structural and stool/fecal-based tests. Although some techniques are better established than others, panelists agreed that any screening is better than none. Structural Screening Tests Structural tests are able to detect both early cancer and adenomatous polyps using endoscopic or radiologic imaging. These have several limitations, including their relative invasiveness, the need for dietary preparation and bowel cleansing, and the time dedicated to the examination (typically a day). Endoscopic examinations require informed consent and sedation, and have related risks, including perforation and bleeding. Recently, a large cohort study of 53,220 Medicare patients between ages 66 and 95 years showed that risk for adverse events after colonoscopy increases with age. Colonoscopy Colonoscopy is the most complete...
  • 1.

    JemalASiegelRWardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:225249.

  • 2.

    LevinBLiebermanDAMcFarlandB. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin2008;58:130160.

    • Search Google Scholar
    • Export Citation
  • 3.

    WarrenJLKlabundeCNMariottoAB. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med2009;150:849857W152.

    • Search Google Scholar
    • Export Citation
  • 4.

    CitardaFTomaselliGCapocacciaR. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut2001;48:812815.

    • Search Google Scholar
    • Export Citation
  • 5.

    WinawerSJZauberAGHoMN. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med1993;329:19771981.

    • Search Google Scholar
    • Export Citation
  • 6.

    MullerADSonnenbergA. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med1995;123:904910.

    • Search Google Scholar
    • Export Citation
  • 7.

    BaxterNNGoldwasserMAPaszatLF. Association of colonoscopy and death from colorectal cancer. Ann Intern Med2009;150:18.

  • 8.

    BarclayRLVicariJJDoughtyAS. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med2006;355:25332541.

    • Search Google Scholar
    • Export Citation
  • 9.

    RadaelliFMeucciGSgroiGMinoliG. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol2008;103:11221130.

    • Search Google Scholar
    • Export Citation
  • 10.

    RexDKCummingsOWHelperDJ. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology1996;111:11781181.

    • Search Google Scholar
    • Export Citation
  • 11.

    ImperialeTFGlowinskiEALin-CooperC. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med2008;359:12181224.

    • Search Google Scholar
    • Export Citation
  • 12.

    LiebermanDAWeissDGHarfordWV. Five-year colon surveillance after screening colonoscopy. Gastroenterology2007;133:10771085.

  • 13.

    SelbyJVFriedmanGDQuesenberryCPJrWeissNS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med1992;326:653657.

    • Search Google Scholar
    • Export Citation
  • 14.

    SinghHTurnerDXueL. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA2006;295:23662373.

    • Search Google Scholar
    • Export Citation
  • 15.

    BrennerHChang-ClaudeJSeilerCM. Does a negative screening colonoscopy ever need to be repeated?Gut2006;55:11451150.

  • 16.

    RobertsonDJBurkeCAWelchHG. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med2009;151:103109.

    • Search Google Scholar
    • Export Citation
  • 17.

    NewcombPANorfleetRGStorerBE. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst1992;84:15721575.

  • 18.

    WeissfeldJLSchoenREPinskyPF. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst2005;97:989997.

    • Search Google Scholar
    • Export Citation
  • 19.

    Investigators UFSST. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet2002;359:12911300.

    • Search Google Scholar
    • Export Citation
  • 20.

    SegnanNSenoreCAndreoniB. Baseline findings of the Italian multicenter randomized controlled trial of ``once-only sigmoidoscopy''--SCORE. J Natl Cancer Inst2002;94:17631772.

    • Search Google Scholar
    • Export Citation
  • 21.

    GondalGGrotmolTHofstadB. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol2003;38:635642.

    • Search Google Scholar
    • Export Citation
  • 22.

    KimDHPickhardtPJTaylorAJMeniasCO. Imaging evaluation of complications at optical colonoscopy. Curr Probl Diagn Radiol2008;37:165177.

    • Search Google Scholar
    • Export Citation
  • 23.

    WhitlockEPLinJSLilesE. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med2008;149:638658.

    • Search Google Scholar
    • Export Citation
  • 24.

    JohnsonCDChenMHToledanoAY. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med2008;359:12071217.

  • 25.

    JohnsonCDHarmsenWSWilsonLA. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology2003;125:311319.

    • Search Google Scholar
    • Export Citation
  • 26.

    RockeyDCPaulsonENiedzwieckiD. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet2005;365:305311.

    • Search Google Scholar
    • Export Citation
  • 27.

    PickhardtPJChoiJRHwangI. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med2003;349:21912200.

    • Search Google Scholar
    • Export Citation
  • 28.

    HalliganSAltmanDGTaylorSA. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology2005;237:893904.

    • Search Google Scholar
    • Export Citation
  • 29.

    MulhallBPVeerappanGRJacksonJL. Meta-analysis: computed tomographic colonography. Ann Intern Med2005;142:635650.

  • 30.

    KimDHPickhardtPJTaylorAJ. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med2007;357:14031412.

    • Search Google Scholar
    • Export Citation
  • 31.

    Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation BoRER, Division on Earth and Life Sciences, and National Research Council of the National Academies. Health risks from exposure to low levels of ionizing radiation: BEIR VII, phase 2. Available at: http://www.nap.edu/catalog.php?record_id=11340. Washington, DC: The National Academies Press; 2006.

    • Export Citation
  • 32.

    HewitsonPGlasziouPWatsonE. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol2008;103:15411549.

    • Search Google Scholar
    • Export Citation
  • 33.

    AllisonJETekawaISRansomLJAdrainAL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med1996;334:155159.

    • Search Google Scholar
    • Export Citation
  • 34.

    HundtSHaugUBrennerH. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med2009;150:162169.

    • Search Google Scholar
    • Export Citation
  • 35.

    HolLVan LeerdamMEVan BallegooijenM. Screening For colorectal cancer; randomised trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut2009; in press.

    • Search Google Scholar
    • Export Citation
  • 36.

    SoxHC. Office-based testing for fecal occult blood: do only in case of emergency. Ann Intern Med2005;142:146148.

  • 37.

    CollinsJFLiebermanDADurbinTEWeissDG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med2005;142:8185.

    • Search Google Scholar
    • Export Citation
  • 38.

    OsbornNKAhlquistDA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology2005;128:192206.

  • 39.

    ImperialeTFRansohoffDFItzkowitzSH. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med2004;351:27042714.

    • Search Google Scholar
    • Export Citation
  • 40.

    AhlquistDASargentDJLoprinziCL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med2008;149:441450W481.

    • Search Google Scholar
    • Export Citation
  • 41.

    HeresbachDBarriozTLapalusMG. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy2008;40:284290.

    • Search Google Scholar
    • Export Citation
  • 42.

    ChowELiptonLLynchE. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology2006;131:3039.

    • Search Google Scholar
    • Export Citation
  • 43.

    RubioCAStemmeSJaramilloELindblomA. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy2006;38:266270.

  • 44.

    YeomanAYoungJArnoldJ. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J2007;120:U2827.

    • Search Google Scholar
    • Export Citation
  • 45.

    FerrandezASamowitzWDiSarioJABurtRW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol2004;99:20122018.

    • Search Google Scholar
    • Export Citation
  • 46.

    LeggettBADevereauxBBidenK. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol2001;25:177184.

  • 47.

    WinawerSJZauberAGFletcherRH. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin2006;56:143159.

    • Search Google Scholar
    • Export Citation
  • 48.

    O'BrienMJWinawerSJZauberAG. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology1990;98:371379.

    • Search Google Scholar
    • Export Citation
  • 49.

    GolembeskiCMcKennaBAppelmanHD. Advanced adenomas: pathologists don't agree. Modern Pathology2007;20:115A.

  • 50.

    BrookerJCSaundersBPShahSG. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc2002;56:333338.

    • Search Google Scholar
    • Export Citation
  • 51.

    GreenRJMetlayJPPropertK. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med2002;136:261269.

    • Search Google Scholar
    • Export Citation
  • 52.

    RexDKKahiCJLevinB. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin2006;56:160167.

    • Search Google Scholar
    • Export Citation
  • 53.

    Rodriguez-MorantaFSaloJArcusaA. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol2006;24:386393.

    • Search Google Scholar
    • Export Citation
  • 54.

    ShureiqiICooksleyCDMorrisJ. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst2001;93:12641266.

  • 55.

    BurtRNeklasonDW. Genetic testing for inherited colon cancer. Gastroenterology2005;128:16961716.

  • 56.

    GiardielloFMOfferhausJG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer1995;31A:10851087.

  • 57.

    HamiltonSRLiuBParsonsRE. The molecular basis of Turcot's syndrome. N Engl J Med1995;332:839847.

  • 58.

    HampelHFrankelWLMartinE. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol2008;26:57835788.

    • Search Google Scholar
    • Export Citation
  • 59.

    LynchHTde la ChapelleA. Hereditary colorectal cancer. N Engl J Med2003;348:919932.

  • 60.

    ChungDCRustgiAK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med2003;138:560570.

    • Search Google Scholar
    • Export Citation
  • 61.

    LoukolaAEklinKLaihoP. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res2001;61:45454549.

    • Search Google Scholar
    • Export Citation
  • 62.

    JarvinenHJMecklinJPSistonenP. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology1995;108:14051411.

    • Search Google Scholar
    • Export Citation
  • 63.

    LindorNMPetersenGMHadleyDW. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA2006;296:15071517.

    • Search Google Scholar
    • Export Citation
  • 64.

    HendriksYMde JongAEMorreauH. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin2006;56:213225.

    • Search Google Scholar
    • Export Citation
  • 65.

    CaldesTGodinoJSanchezA. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep2004;12:621629.

    • Search Google Scholar
    • Export Citation
  • 66.

    VasenHFHendriksYde JongAE. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers2004;20:207213.

    • Search Google Scholar
    • Export Citation
  • 67.

    LindorNMBurgartLJLeontovichO. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol2002;20:10431048.

    • Search Google Scholar
    • Export Citation
  • 68.

    PinolVCastellsAAndreuM. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA2005;293:19861994.

    • Search Google Scholar
    • Export Citation
  • 69.

    ShiaJKlimstraDSNafaK. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol2005;29:96104.

    • Search Google Scholar
    • Export Citation
  • 70.

    HampelHFrankelWPanescuJ. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res2006;66:78107817.

    • Search Google Scholar
    • Export Citation
  • 71.

    ReyesCMAllenBATerdimanJPWilsonLS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer2002;95:18481856.

    • Search Google Scholar
    • Export Citation
  • 72.

    Rodriguez-BigasMABolandCRHamiltonSR. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst1997;89:17581762.

    • Search Google Scholar
    • Export Citation
  • 73.

    UmarABolandCRTerdimanJP. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst2004;96:261268.

    • Search Google Scholar
    • Export Citation
  • 74.

    RaedleJTrojanJBriegerA. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med2001;135:566576.

    • Search Google Scholar
    • Export Citation
  • 75.

    VasenHF. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol2000;18:81S92S.

  • 76.

    Lagerstedt RobinsonKLiuTVandrovcovaJ. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst2007;99:291299.

    • Search Google Scholar
    • Export Citation
  • 77.

    RamseySDClarkeLEtzioniR. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med2001;135:577588.

    • Search Google Scholar
    • Export Citation
  • 78.

    BalmanaJStockwellDHSteyerbergEW. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA2006;296:14691478.

  • 79.

    BarnetsonRATenesaAFarringtonSM. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med2006;354:27512763.

    • Search Google Scholar
    • Export Citation
  • 80.

    ChenSWangWLeeS. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA2006;296:14791487.

  • 81.

    KohlmannWGruberS. Hereditary Non-Polyposis Colon Cancer. Available athttp://www.genetests.org. Accessed 09/18/09. GeneReviews at GeneTests: Medical Genetics Information Reseource (datebase online). Seattle: University of Washington; 1997–2009.

    • Search Google Scholar
    • Export Citation
  • 82.

    WatsonPVasenHFMecklinJP. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer2008;123:444449.

  • 83.

    SchulmannKEngelCProppingPSchmiegelW. Small bowel cancer risk in Lynch syndrome. Gut2008;57:16291630.

  • 84.

    GaliatsatosPFoulkesWD. Familial adenomatous polyposis. Am J Gastroenterol2006;101:385398.

  • 85.

    BurtRWLeppertMFSlatteryML. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology2004;127:444451.

    • Search Google Scholar
    • Export Citation
  • 86.

    AbrahamSCNobukawaBGiardielloFM. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol2000;157:747754.

    • Search Google Scholar
    • Export Citation
  • 87.

    GuillemJGWoodWCMoleyJF. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol2006;24:46424660.

    • Search Google Scholar
    • Export Citation
  • 88.

    AmbrozeWLJrDozoisRRPembertonJH. Familial adenomatous polyposis: results following ileal pouch-anal anastomosis and ileorectostomy. Dis Colon Rectum1992;35:1215.

    • Search Google Scholar
    • Export Citation
  • 89.

    MaddenMVNealeKFNichollsRJ. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis. Br J Surg1991;78:789792.

    • Search Google Scholar
    • Export Citation
  • 90.

    SoraviaCKleinLBerkT. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum1999;42:10281033.

    • Search Google Scholar
    • Export Citation
  • 91.

    Van DuijvendijkPSlorsJFTaatCW. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg2000;87:590596.

    • Search Google Scholar
    • Export Citation
  • 92.

    van DuijvendijkPSlorsJFTaatCW. Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg1999;230:648654.

    • Search Google Scholar
    • Export Citation
  • 93.

    ZivYChurchJMOakleyJR. Surgery for the teenager with familial adenomatous polyposis: ileo-rectal anastomosis or restorative proctocolectomy?Int J Colorectal Dis1995;10:69.

    • Search Google Scholar
    • Export Citation
  • 94.

    BjorkJAAkerbrantHIIseliusLEHultcrantzRW. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis Colon Rectum2000;43:17191725.

    • Search Google Scholar
    • Export Citation
  • 95.

    De CosseJJBulowSNealeK. Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg1992;79:13721375.

    • Search Google Scholar
    • Export Citation
  • 96.

    VasenHFvan DuijvendijkPBuskensE. Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. Gut2001;49:231235.

    • Search Google Scholar
    • Export Citation
  • 97.

    BulowSBulowCVasenH. Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum2008;51:13181323.

    • Search Google Scholar
    • Export Citation
  • 98.

    ChurchJBurkeCMcGannonE. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum2003;46:11751181.

    • Search Google Scholar
    • Export Citation
  • 99.

    NugentKPPhillipsRK. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg1992;79:12041206.

    • Search Google Scholar
    • Export Citation
  • 100.

    GroenEJRoosAMuntingheFL. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol2008;15:24392450.

  • 101.

    ChurchJLynchCNearyP. A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum2008;51:897901.

    • Search Google Scholar
    • Export Citation
  • 102.

    AretzSKochAUhlhaasS. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?Pediatr Blood Cancer2006;47:811818.

    • Search Google Scholar
    • Export Citation
  • 103.

    AttardTMGiglioPKoppulaS. Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer2007;109:761766.

    • Search Google Scholar
    • Export Citation
  • 104.

    GiardielloFMOfferhausGJLeeDH. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut1993;34:13941396.

    • Search Google Scholar
    • Export Citation
  • 105.

    SpigelmanADWilliamsCBTalbotIC. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet1989;2:783785.

  • 106.

    SaurinJCGutknechtCNapoleonB. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol2004;22:493498.

    • Search Google Scholar
    • Export Citation
  • 107.

    BaronJAColeBFSandlerRS. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med2003;348:891899.

  • 108.

    ChanATGiovannucciELMeyerhardtJA. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA2005;294:914923.

    • Search Google Scholar
    • Export Citation
  • 109.

    SandlerRSHalabiSBaronJA. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med2003;348:883890.

    • Search Google Scholar
    • Export Citation
  • 110.

    Cruz-CorreaMHylindLMRomansKE. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology2002;122:641645.

    • Search Google Scholar
    • Export Citation
  • 111.

    GiardielloFMYangVWHylindLM. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med2002;346:10541059.

  • 112.

    ArberNEagleCJSpicakJ. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med2006;355:885895.

  • 113.

    BaronJASandlerRSBresalierRS. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology2006;131:16741682.

    • Search Google Scholar
    • Export Citation
  • 114.

    BertagnolliMMEagleCJZauberAG. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med2006;355:873884.

  • 115.

    SteinbachGLynchPMPhillipsRK. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med2000;342:19461952.

    • Search Google Scholar
    • Export Citation
  • 116.

    BertagnolliMMEagleCJZauberAG. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila Pa)2009;2:310321.

    • Search Google Scholar
    • Export Citation
  • 117.

    BresalierRSSandlerRSQuanH. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med2005;352:10921102.

    • Search Google Scholar
    • Export Citation
  • 118.

    SolomonSDMcMurrayJJPfefferMA. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med2005;352:10711080.

    • Search Google Scholar
    • Export Citation
  • 119.

    BallhausenWG. Genetic testing for familial adenomatous polyposis. Ann N Y Acad Sci2000;910:3647.

  • 120.

    MihalatosMApessosAPapadopoulouE. Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer. Anticancer Res2003;23:21912193.

    • Search Google Scholar
    • Export Citation
  • 121.

    GiardielloFMBrensingerJDPetersenGM. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med1997;336:823827.

    • Search Google Scholar
    • Export Citation
  • 122.

    Al-TassanNChmielNHMaynardJ. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet2002;30:227232.

    • Search Google Scholar
    • Export Citation
  • 123.

    JonesSEmmersonPMaynardJ. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet2002;11:29612967.

    • Search Google Scholar
    • Export Citation
  • 124.

    JoWSBandipalliamPShannonKM. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol2005;3:10221028.

    • Search Google Scholar
    • Export Citation
  • 125.

    WangLBaudhuinLMBoardmanLA. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology2004;127:916.

    • Search Google Scholar
    • Export Citation
  • 126.

    BalaguerFCastellvi-BelSCastellsA. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol2007;5:379387.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 523 523 53
PDF Downloads 69 69 6
EPUB Downloads 0 0 0